Δευτέρα 23 Ιανουαρίου 2017

Misperceptions of metastatic breast cancer (mBC) create added obstacles for treatment and care

A first-of-its-kind global report by Pfizer Oncology and the European School of Oncology (ESO) analyses the metastatic breast cancer landscape A diagnosis of mBC can be the beginning of a challenging journey for patients. MBC is often shroud-ed by...

from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2jh2A5z
via IFTTT

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου

Δημοφιλείς αναρτήσεις